Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal Magnetic Resonance Imaging Study on the Neural Mechanisms of Remission in Children With ADHD Treated With Methylphenidate or Atomoxetine

NCT05229627 is registered in ClinicalTrials.gov with Peking University Sixth Hospital as lead sponsor.

NCT NCT05229627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05229627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal Magnetic Resonance Imaging Study on the Neural Mechanisms of Remission in Children With ADHD Treated With Methylphenidate or Atomoxetine
Lead sponsor
Peking University Sixth Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2016
Completion date
December 31, 2023
Enrollment
250 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adhd